Muro K - Search Results

1

Prognostic significance of DNA replication errors in young patients with colorectal cancer.

Lukish JR, Muro K, DeNobile J, Katz R, Williams J, Cruess DF, Drucker W, Kirsch I, Hamilton SR. Lukish JR, et al. Among authors: muro k. Ann Surg. 1998 Jan;227(1):51-6. doi: 10.1097/00000658-199801000-00008. Ann Surg. 1998. PMID: 9445110 Free PMC article.

2

APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis.

Giardiello FM, Petersen GM, Piantadosi S, Gruber SB, Traboulsi EI, Offerhaus GJ, Muro K, Krush AJ, Booker SV, Luce MC, Laken SJ, Kinzler KW, Vogelstein B, Hamilton SR. Giardiello FM, et al. Among authors: muro k. Gut. 1997 Apr;40(4):521-5. doi: 10.1136/gut.40.4.521. Gut. 1997. PMID: 9176082 Free PMC article.

3

Intraoperative electromagnetic navigational bronchoscopic localization of small, deep, or subsolid pulmonary nodules.

Abbas A, Kadakia S, Ambur V, Muro K, Kaiser L. Abbas A, et al. Among authors: muro k. J Thorac Cardiovasc Surg. 2017 Jun;153(6):1581-1590. doi: 10.1016/j.jtcvs.2016.12.044. Epub 2017 Feb 7. J Thorac Cardiovasc Surg. 2017. PMID: 28314525 Free article.

4

Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.

Shimomura K, Ogata T, Maeda A, Narita Y, Taniguchi H, Murotani K, Fujiwara Y, Tajika M, Hara K, Muro K, Uchida K. Shimomura K, et al. Among authors: muro k. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01503-6. Online ahead of print. Invest New Drugs. 2025. PMID: 39789368

5

Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS.

Komori A, Hironaka S, Kadowaki S, Mitani S, Furuta M, Kawakami T, Makiyama A, Takegawa N, Sugiyama K, Hirano H, Ando T, Matsushima T, Chida A, Kashiwada T, Komoda M, Matsumoto T, Oda H, Yabusaki H, Kawakami H, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K; West Japan Oncology Group (WJOG). Komori A, et al. Among authors: muro k. Gastric Cancer. 2024 Dec 31. doi: 10.1007/s10120-024-01579-2. Online ahead of print. Gastric Cancer. 2024. PMID: 39738793

6

Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.

Narita Y, Mizuno T, Ishizuka Y, Sakakida T, Masuishi T, Taniguchi H, Kadowaki S, Honda K, Ando M, Tajika M, Takahari D, Muro K. Narita Y, et al. Among authors: muro k. Oncologist. 2024 Dec 2:oyae328. doi: 10.1093/oncolo/oyae328. Online ahead of print. Oncologist. 2024. PMID: 39673418 Free article.

7

[Lower G. I. /Colon and Rectum Cancer Changes in the Japanese Society for Cancer of the Colon and Rectum(JSCCR)Guidelines 2024 for the Treatment of Colorectal Cancer].

Muro K. Muro K. Gan To Kagaku Ryoho. 2024 Nov;51(11):1119. Gan To Kagaku Ryoho. 2024. PMID: 39648124 Japanese. No abstract available.

8

Impact of ABCB1 single-nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin-bound paclitaxel in patients with gastric cancer.

Maeda A, Matsuo K, Ando H, Morishige JI, Muro K, Uchida K, Tajika M. Maeda A, et al. Among authors: muro k. Br J Clin Pharmacol. 2024 Dec 2. doi: 10.1111/bcp.16359. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 39622587

9

International experts consensus on optimal central vascular access device selection and management for patients with cancer.

Jahanzeb M, Wu CY, Lim H, Muro K, Xu L, Somashekhar M, Sampige Prasannakumar Somashekhar SP, Zhang X, Qiu X, Fu Y, Pittiruti M. Jahanzeb M, et al. Among authors: muro k. J Vasc Access. 2024 Dec 2:11297298241300792. doi: 10.1177/11297298241300792. Online ahead of print. J Vasc Access. 2024. PMID: 39620855

10

Correction: Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study).

Kawakami H, Nakanishi K, Makiyama A, Konishi H, Morita S, Narita Y, Sugimoto N, Minashi K, Imano M, Inamoto R, Kodera Y, Kume H, Yamaguchi K, Hashimoto W, Muro K; EN-DEAVOR Study Group. Kawakami H, et al. Among authors: muro k. Gastric Cancer. 2025 Jan;28(1):62. doi: 10.1007/s10120-024-01570-x. Gastric Cancer. 2025. PMID: 39607631 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters